Background: Depression can interfere with the normal expression of cognitive abilities in adults of all ages, but it is unclear if depression in demented people, which is common, is associated with reduced cognitive performance beyond the effect of the dementia itself.
R EPORTED DEPRESSION IS COMmon in people with dementia. Epidemiological data indicate prevalence rates of 30% to 50% for significant depressive symptoms among people with dementia of the Alzheimer type (DAT). 1 Rates of depression may be higher in the earlier stages of Alzheimer disease. 2 Even in cognitively normal younger or older adults, depression can interfere with the normal expression of cognitive abilities. Although the results of studies are somewhat mixed, slowed mental processing and deficits in attention and executive function seem to be more likely in depressed than in nondepressed individuals in the absence of dementia. 3, 4 Individuals with lateonset depression have more significant cognitive impairment. 5 We know less, however, about whether depression in demented people is associated with reduced cognitive performance beyond the effect of the dementia itself. That is, if dementia severity were held constant, would depressed de-mented people perform more poorly than nondepressed demented people? Addressing this question was the primary goal of the present study.
Individuals who are diagnosed as having depression and dementia are reported to have excess impairment in functional abilities. [6] [7] [8] [9] [10] Results of studies looking at specific cognitive abilities have been less definitive. Most of these studies [11] [12] [13] [14] [15] found no differenceincognitiveperformancebetween depressed DAT patients and nondepressed DATpatients.Asinglestudy 16 foundpatients with DAT and depression performed worse than DAT patients without depression on tasks of attention and psychomotor speed. Therefore, one reason for the conflicting reports may be related to the measures of cognition examined. Depression may have an added effect on timed tasks or measures of attention but not on tests of memory, which is already severely affected by dementia. Also, it is possible that an added effect of depression may be seen in some stages of dementia but not others. 7 In this study, we used information about the stage of dementia to group people with similar degrees of dementia severity and examined performance on several specific neuropsychological tests. We expected to see the greatest cognitive impairment in demented people with depression on those cognitive tasks shown previously to be especially susceptible to the effects of depression in cognitively normal younger and older adults. 3, 4 Therefore, a second goal of the present study was to determine whether diagnosed depression or reports of depressive features in demented individuals were associated with additional impairment in performance, particularly on timed tasks or tasks requiring effortful attention.
METHODS

SAMPLE
Data were available for 322 individuals with DAT who were enrolled in a longitudinal study at an Alzheimer disease research center in a midwestern urban area and who came in for an annual evaluation between October 21, 1996, and March 27, 2002 . Only the first assessment during that period was included for individuals who returned for more than 1 assessment. Other data from many of these participants have appeared in numerous publications from the center. The project was approved by a university institutional review board.
Experienced clinicians assessed each older adult for the presence and severity of dementia using the Clinical Dementia Rating 17 based on a 90-minute semistructured interview with the research participant and a knowledgeable collateral source (usually a spouse or adult child), followed by a neurological examination of the participant. The diagnosis of DAT was based on a history of gradual onset and progressive cognitive impairment and was comparable to that specified in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 18 Diagnostic accuracy for Alzheimer disease as verified by postmortem examination in 207 individuals is 93%. 19 The clinician who conducted the evaluation also determined if depression was active; it was in 19% of the participants. All categories of depression except simple bereavement were included in the diagnosis of depression. 18 Individuals with other medical or psychiatric conditions that might affect cognition were excluded.
The Clinical Dementia Rating describes the severity of dementia along 6 dimensions: memory, orientation, judgment and problem solving, community affairs, home and hobbies, and personal care. Only people with a global Clinical Dementia Rating of 0.5 (very mild, n = 167) or 1 (mild, n = 155) were included in the analyses. Demographic information for the 2 groups is shown in Table 1 . The very mildly demented group was slightly younger (t 320 = 2.64, PϽ.01) and better educated (t 320 = 3.41, PϽ.001) than the mildly demented group; it also contained proportionally more men ( 2 1 = 6.84, PϽ.01). The clinicians judged depression to be present in a higher percentage (24% vs 15%) of the mildly demented group than the very mildly demented group ( 2 1 = 4.10, PϽ.05).
MEASURES
Depressive Features
The participant was asked if the following depressive features had occurred for 2 weeks or more in the past year: depressed mood, diminished interest, change in weight or appetite, sleep disturbance, fatigue, psychomotor disturbance, feelings of worthlessness, indecisiveness, and suicidal ideation. The depressive features score was the sum of the endorsed features. A similar score was obtained from the collateral source, who was also asked if these features had occurred in the participant. Previous work has suggested that the collateral source is important to the diagnosis of depression in demented individuals. 20, 21 Psychometric Battery 23 ; Boston Naming Test 24 ; word fluency for S and P (60 seconds allowed for each letter) 25 ; information, block design, and digit symbol subtests of the Wechsler Adult Intelligence Scale 26 ; Trail-Making Test A 27 ; and Crossing-off. 28 The standard tests were administered according to their manuals except for the Boston Naming Test, for which all items were administered and no cues were given. A high score indicates good performance on all tests except the Trail-Making Test, for which the score was time; a cutoff of 180 seconds was used. In addition to the scores for each test in the battery, a factor score was computed using all the tests in the battery. The means, standard deviations, and weights used to compute this composite were based on a principal components analysis of 81 nondemented individuals that revealed a single component accounting for 37% of the variance. 29 
STATISTICAL ANALYSIS
Because dementia severity affects level of performance on the psychometric tests, correlations between the psychometric scores and the 3 indexes of depression (clinician's judgment and number of depressive features reported by the participant and collateral source) were computed for the very mildly and mildly demented groups separately.
RESULTS AND COMMENT
The correlations between the psychometric scores and the measures of depression are shown in Table 2 . The only anticipated pattern of poorer performance in timed or attention-requiring tests was in the mildly demented group. Poorer performance on 3 timed tests (block design, digit symbol, and Trail-Making A) was modestly correlated with reports of more depressive features by the participants.
The value of the participant's report of depressive features is important in light of the lack of the *Data are given as mean (SD) unless otherwise indicated.
(REPRINTED) ARCH NEUROL / VOL 61, AUG 2004 expected correlations (Table 2) between the timed and attentional test results and the clinician's diagnosis of depression or the number of depressive features reported by the collateral source. The clinician and the collateral source may have difficulty differentiating depression from cognitive impairment, especially as the cognitive impairment progresses. The correlations among the 3 reports of depression (from the participant, collateral source, and clinician) ranged from 0.36 to 0.42 in the very mild dementia group. In the mild dementia group the reports of depressive features by the collateral and clinical sources were similarly related (r = 0.43), but the depression scores provided by participants were less strongly related to those of the collateral source (r = 0.20) and clinician (r = 0.25). It has long been noted that the differential diagnosis of depression and dementia in older adults can be difficult because symptoms of depression and dementia overlap considerably. 20, 21, 29 Therefore, some older individuals may appear to have dementia when they are depressed instead. The present results indicate a related problem. That is, features of depression include diminished interest in work or hobbies and indecisiveness, which could be mistaken as impairments in functional activities resulting from cognitive impairment. These overlapping symptoms may make it difficult to determine whether a demented individual has depression as well. It is therefore important to give credence to the demented person's reports of symptoms of depression. It is somewhat surprising, however, that this modest pattern of correlation between the demented individual's report of depressive features and performance on timed tests was seen in the mildly demented group rather than in the very mildly demented group, in whom one might expect greater insight. Therefore, although these modest correlations occurred where they were expected to, it is possible that they represent type I errors, given the large number of correlations computed.
Our results show that there was little relation between the indexes of depression and performance on this battery of psychometric tests. Those correlations that were statistically significant at ␣ = 0.05 were small in magnitude (Յ0. 21 ). It appears that the deleterious effect of major depression on test performance seen in nondemented individuals 4 is superseded by the global effect of the dementia in people with Alzheimer disease. 
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